Abstract:Objective To prepare sirolimus(SRL)-loaded nanoparticles (NPs), and to apply them in acellular bi-ological vascular material. Methods The SRL poly (lactic-co-glycolic) acid (PLGA)-NPs (SRL-PLGA-NPs) was pre-pared by interface precipitation method, using the biodegradable polymer material, PLGA loaded matrix. The laser particle size analyzer and scanning electron microscope were used to measure the particle size and morphology of the NPs. The high performance liquid chromatography (HPLC) was used to determine the drug load and encapsulation ef-ficiency of the NPs. The double-chamber diffusion cells were used for in vitro release experiment of the NPs. The acel-lular and heparin treated canine carotid was used to prepare biological artificial vascular material. The endovascular local perfusion was used to combine the NPs with the vascular material, which were divided into 4 groups based on different perfusion time [120 s (group A), 240 s (group B), 360 s (group C) and 480 s (group D)]. The drug concentra-tion of the vascular tissues in each group was regularly determined. Results The SRL-PLGA-NPs were successfully prepared, with the particle size of 227-303 nm, mean particle size of (265±24)nm, encapsulation efficiency of 81.53%, and mean drug load of 18.96%. The SRL-PLGA-NPs could continuously release drugs in 30 d. 75%of the drug was released at 2 weeks, and 90%of the drug was released at 30 d. After SRL-PLGA-NPs acellular endovascular perfusion at 21 d, Sirolimus could still be determined in the vascular tissues, which showed a gradually decreased trend. The drug concentration in group A at perfusion and 1d after perfusion were lower than those in the other three groups ( P<0.05). However, there were no significant differences in the drug concentration among the 4 groups at 3, 7, 14 and 21 d after the perfusion (P>0.05). Conclusion Using interface precipitation method to prepare SRL-PLGA-NPs is stable and reliable, which has satisfied effects on local perfusion in acellular biological vascular material.

Lipids-based Nanostructured Lipid Carriers (nlcs) for Improved Oral Bioavailability of Sirolimus.

Enhanced Bioavailability by Orally Administered Sirolimus Nanocrystals.

Binary lipids-based nanostructured lipid carriers for improved oral bioavailability of silymarin.

Sirolimus Solid Self-Microemulsifying Pellets: Formulation Development, Characterization and Bioavailability Evaluation.

Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile salt.

Enhancement of Oral Bioavailability of Cyclosporine A: Comparison of Various Nanoscale Drug-Delivery Systems.

Preparation and in vivo and ex vivo studies of sirolimus nano-in-situ gel ophthalmic formulation

Intestinal Absorption and Intestinal Lymphatic Transport of Sirolimus from Self-Microemulsifying Drug Delivery Systems Assessed Using the Single-Pass Intestinal Perfusion (SPIP) Technique and a Chylomicron Flow Blocking Approach: Linear Correlation with Oral Bioavailabilities in Rats

Preparation of sirolimus-loaded nanoparticles and its application in acellular biological vascular material

Silymarin Glyceryl Monooleate/Poloxamer 407 Liquid Crystalline Matrices: Physical Characterization and Enhanced Oral Bioavailability

Preparation and Properties in vitro of Sirolimus Dropping Pills

Preparation and Characterization of Silybin-Loaded Nanostructured Lipid Carriers

Sirolimus formulation with improved pharmacokinetic properties produced by a continuous flow method

Effect of Surface Property on the Release and Oral Absorption of Solid Sirolimus-Containing Self-microemulsifying Drug Delivery System

Improved Oral Bioavailability and Liver Targeting of Sorafenib Solid Lipid Nanoparticles in Rats

Glyceryl Monooleate/Poloxamer 407 Cubic Nanoparticles As Oral Drug Delivery Systems: I. in Vitro Evaluation and Enhanced Oral Bioavailability of the Poorly Water-Soluble Drug Simvastatin

Nanostructured Lipid Carriers for Parenteral Delivery of Silybin: Biodistribution and Pharmacokinetic Studies.

In vitro and in vivo studies of lipid-based nanocarriers for oral N<sub>3</sub>-o-toluyl-fluorouracil delivery

Formulation Design and Evaluation of Self-Microemulsifying Drug Delivery System of Sirolimus

Enhancement of oral bioavailability of ibrutinib using a liposil nanohybrid delivery system

Sirolimus‐loaded polymeric micelles with honokiol for oral delivery